» Articles » PMID: 126564

Immunoadjuvant Activities of Cell Walls, Their Water-soluble Fractions and Peptidoglycan Subunits, Prepared from Various Gram-positive Bacteria, and of Synthetic N-acetylmuramyl Peptides

Overview
Date 1975 Jul 1
PMID 126564
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

1. The cell walls from some 20 species of gram-positive bacteria, with only few exceptions, were found to be definitely adjuvant-active in both stimulation of increased serum antibody levels and induction of delayed-type hypersensitivity to ovalbumin when administered to guinea pigs in the form of a water-in-oil emulsion. 2. By the use of various cell wall lytic enzymes, the immunoadjuvant principles were solubilized with the full retention of adjuvant activities observed with the cell walls of S. aureus, Str. pyogenes, Str. mutans, L. plantarum, C. diphtheriae, Myc. smegmatis and A. viscosus. N-acetylmuramyl peptide monomers (either L-Lys or meso-Dap type) were shown to be the unit chemical structure responsible for the manifestation of adjuvant activities to stimulate both antibody-mediated and cell-mediated immune responses. 3. Several N-Acetylmuramyl peptides were prepared by condensation of benzyl N-acetyl-4,6-O-benzylidene-alpha-muramide with each peptide benzyl ester by means of dicyclohexylcarbodiimide-N-hydroxysuccinimide method and removal of the protecting groups by hydrogenolysis. N-acetylmuramyl-L-alanyl-D-isoglutamine was identified as the minimum structural entity essential for the immunoadjuvant activities characteristic of bacterial cell walls. Neither synthetic N-acetylmuramyl-L-alanine nor L-alanyl-D-isoglutaminyl-L-lysyl-D-alanin was found to be active.

Citing Articles

Peptide ILE-GLU-TRP (Stemokin) Potential Adjuvant Stimulating a Balanced Immune Response.

Deigin V, Koroev D, Volpina O Int J Pept Res Ther. 2022; 28(6):156.

PMID: 36313476 PMC: 9589648. DOI: 10.1007/s10989-022-10461-7.


Strategies for Using Muramyl Peptides - Modulators of Innate Immunity of Bacterial Origin - in Medicine.

Guryanova S, Khaitov R Front Immunol. 2021; 12:607178.

PMID: 33959120 PMC: 8093441. DOI: 10.3389/fimmu.2021.607178.


Synthetic chemistry with friendships that unveiled the long-lasting mystery of lipid A.

Kawahara K Innate Immun. 2019; 25(3):203-212.

PMID: 30894093 PMC: 6830933. DOI: 10.1177/1753425919835298.


Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Nabergoj S, Mlinaric-Rascan I, Jakopin Z Med Res Rev. 2018; 39(5):1447-1484.

PMID: 30548868 PMC: 6767550. DOI: 10.1002/med.21557.


Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

Maisonneuve C, Bertholet S, Philpott D, De Gregorio E Proc Natl Acad Sci U S A. 2014; 111(34):12294-9.

PMID: 25136133 PMC: 4151741. DOI: 10.1073/pnas.1400478111.